Report - Silence Therapeutics · Myasthenia gravis, C3 Glomerulopathy, atypical Hemolytic Uremic Syndrome or Cold Agglutinin Disease) ... • SLN360, an Lp(a) targeting siRNA for cardiovascular

Please pass captcha verification before submit form